295 results
Page 11 of 15
8-K
EX-99.1
xgjsylja8
12 Apr 11
BioTime Presents Data at FABS 2011 on the Restoration of Cell Lifespan Using iPS Cell Technology
12:00am
8-K
EX-99.1
usdelz3d joyl
6 Apr 11
BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine
12:00am
8-K
EX-99.1
xjlnt5ws
22 Mar 11
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
12:00am
8-K
EX-99.1
7tms7
15 Mar 11
BioTime Announces Fourth Quarter and Fiscal Year 2010 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
rzh5ugqob1
4 Mar 11
Update on ReCyte™ technology for resetting telomere length and its application in cardiovascular disease
12:00am
8-K
EX-99.1
6uqgkycnuxchplu6 rm
14 Feb 11
BioTime Announces Agreement To Acquire Glycosan BioSystems
12:00am
8-K
ciqnz9jdom
28 Jan 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
navqrm4d
28 Jan 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
ds0ots eiz9duyps90
10 Jan 11
BioTime’s CEO Michael West to Present Preclinical Data on OTX-CP03 and OTX-CP07 for the Treatment of Osteoarthritis at STEM 2011 in Gurgaon, India
12:00am
8-K
EX-99.1
9bqb41pw
3 Jan 11
BioTime Subsidiary ReCyte Therapeutics, Inc. to Develop Therapies for Age-Related Cardiovascular and Blood Disorders
12:00am
8-K
EX-99.1
0ziid7 g7kzb
22 Dec 10
BioTime, Inc. and the University of California System Sign Cell Transfer Agreement for Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
ghpr3
9 Dec 10
BioTime Asia, Limited and Shanghai Genext Medical Technology Co., Ltd. Sign Marketing Agreement for ACTCellerate™ Cell Lines
12:00am
8-K
EX-99.1
wvokcw
3 Dec 10
Other Events
12:00am
8-K
EX-99.1
gsufj 04ljxqz0
29 Nov 10
BioTime, Inc. and the California Institute for Regenerative Medicine Sign Distribution Agreement for GMP-Compliant Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
1mepmjp7w3q limkp0
10 Nov 10
Other Events
12:00am
8-K
EX-99.1
zm1y5shy inl6kpeng
4 Nov 10
BioTime Announces Final Results of Warrant Exercises
12:00am
8-K
EX-99.1
499bhpec
3 Nov 10
BioTime, Inc. Awarded $733,000 in Grants Under Qualifying Therapeutic Discovery Project Program
12:00am